Lynx Biosciences Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 13
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $5K
Latest Deal Amount
  • Investors
  • 10

Lynx Biosciences General Information

Description

Developer of cancer-detecting technology designed to offer clinical treatment of cancer patients. The company combines physiologically relevant suspension cell co-culture assays, automated microfluidics, and deep learning analytics with the goal of rapidly advancing drug candidates, enabling blood cancer patients and multiple myeloma patients to receive a response on clinical treatment.

Contact Information

Website
www.lynx.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 3210 Merryfield Row
  • San Diego, CA 92121-1126
  • United States

Lynx Biosciences Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lynx Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Grant 24-Oct-2018 $5K 000 Completed Generating Revenue
7. Seed Round 02-Apr-2018 000 Completed Generating Revenue
6. Accelerator/Incubator 02-Apr-2018 000 Completed Generating Revenue
5. Early Stage VC 05-Apr-2017 000 000 Completed Generating Revenue
4. Grant 01-Jan-2017 00000 Completed Startup
3. Grant 13-Oct-2016 00000 Completed Startup
2. Accelerator/Incubator 26-Sep-2016 $5K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Lynx Biosciences’s complete valuation and funding history, request access »

Lynx Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of cancer-detecting technology designed to offer clinical treatment of cancer patients. The company combines p
Biotechnology
San Diego, CA
13 As of 2021
000
0000000000 000

000000

d do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostr
0000000000000 00000000
Boston, MA
000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lynx Biosciences Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000000 Venture Capital-Backed Boston, MA 000 00000 00000000000 00000
You’re viewing 1 of 1 competitors. Get the full list »

Lynx Biosciences Executive Team (2)

Name Title Board Seat Contact Info
Chorom Pak Ph.D Founder, President & Chief Executive Officer
Benjamin Titz Ph.D VP, Corporate Development
To view Lynx Biosciences’s complete executive team members history, request access »

Lynx Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lynx Biosciences Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Quick Pitch Other 000 0000 000000 0
JLABS Accelerator/Incubator 000 0000 000000 0
The Cove Fund Growth/Expansion Minority 000 0000 000000 0
Tech Coast Angels Angel Group Minority 000 0000 000000 0
Wisconsin Economic Development Corporation Government Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »